Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 28, 2004
Reporting Period: Third quarter ended September 30, 2004
This filing serves as a notification that the company issued a press release on October 28, 2004, announcing financial results for the third quarter of 2004. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The filing explicitly states that the financial results are contained within the attached press release (Exhibit 99.1), which is not included in the input text.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific details regarding material changes in financial condition or operations compared to prior periods. It only confirms the issuance of a press release containing these results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued by management but does not include the text of that commentary.
Risks and Contingencies: No specific risks or contingencies are detailed in this document.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release) for specific revenue, earnings, and cash flow figures for the quarter ended September 30, 2004.
- Verify the company's year-to-date performance and any updated full-year guidance provided in the press release.
- Confirm if the press release contains any non-GAAP financial measures or reconciliations.
- Check for any forward-looking statements or risk factors disclosed in the press release that may impact future operations.